...
首页> 外文期刊>European journal of pharmaceutical sciences >The preparation of Cistanche phenylethanoid glycosides liquid proliposomes: Optimized formulation, characterization and proliposome dripping pills in vitro and in vivo evaluation
【24h】

The preparation of Cistanche phenylethanoid glycosides liquid proliposomes: Optimized formulation, characterization and proliposome dripping pills in vitro and in vivo evaluation

机译:钙苯基乙醇糖苷液相色谱法的制备:在体外和体内评价中优化配方,表征和脱脂液滴丸

获取原文
获取原文并翻译 | 示例

摘要

Water-soluble Cistanche phenylethanoid glycosides (CPhGs) have poor permeability and low bioavailability. However, liposomes can improve the permeability of such drugs and their poor stability, and proliposomes have been used to overcome these problems. Based on this, Cistanche phenylethanoid glycoside liquid proliposomes (CPhGsP) and dripping(?) pills were prepared and optimized using response surface methodology. The properties of CPhGsP were evaluated in terms of their encapsulation efficiency, particle size, zeta potential, and morphology. The results obtained showed that the optimal formulation was drug/soybean phospholipid/poloxamer-188/sodium deoxycholate/propylene glycol 1:2238:3.52:0.84:80 (w/w/w/w/v). This resulted in an encapsulation efficiency, particle size, and zeta potential of hydrated proliposomes with phosphate buffer solution (pH 7.4) of 51.97%, 671.7 nm, and -25.49 mV, respectively. Stability testing of CPhGsP and CPhGs ordinary liposomes was carried out for 3 months at 4 +/- 2 degrees C, 25 +/- 2 degrees C, 40 +/- 2 degrees C, 75 +/- 5% RH. The results obtained showed that the stability of the proliposomes was better than that of ordinary liposomes at the same temperature, while a lower temperature of 4 degrees C is ideal for storage. Cistanche phenylethanoid glycoside liquid proliposomes dripping pills (CPhGsPD) are efficiently released in gastrointestinal solution as shown by in vitro release experiments and the structure of the liposomes does not destroy the proliposome dripping pills by hydration. In vivo experiments showed that the areas under the plasma level-time curves and peak concentrations of CPhGsPD and hydrated proliposomes were higher than those of CPhGs. Moreover, with CPhGsPD, the pharmacokinetic parameters were similar to those with hydrated proliposomes. These results showed that CPhGsPD offer a good way to improve the oral delivery.of CPhGs. (C) 2016 Elsevier B.V. All rights reserved.
机译:水溶性岩石苯乙醇苷糖苷(CPHG)具有差的渗透性和低生物利用度。然而,脂质体可以改善这些药物的渗透性及其稳定性差,并且已经使用脱脂剂来克服这些问题。基于此,使用响应表面方法制备和优化脊基苯乙烷苷液体脱脂苷(CPHGSP)和滴水(β)丸。根据其包封效率,粒度,ζ电位和形态评估CPHGSP的性质。得到的结果表明,最佳配方是药物/大豆磷脂/泊洛沙姆-188 /脱氧胆酸钠/丙二醇1:2238:3.52:0.84:80(w / w / w / v)。这导致水合脱脂蛋白酶的封装效率,粒度和Zeta电位,磷酸盐缓冲溶液(pH7.4)分别为51.97%,671.7nm和-25.49mV。 CPHGSP和CPHGS常见脂质体的稳定性测试在4 +/- 2℃,25 +/- 2℃,40 +/- 2℃,75 +/- 5%RH下进行3个月。得到的结果表明,脱脂剂的稳定性优于相同温度的普通脂质体的稳定性,而4℃的较低温度是理想的储存。脊柱苯乙烷醇液体脱脂剂滴眼丸(CPHGSPD)在胃肠溶液中有效地释放,如体外释放实验所示,脂质体的结构不会通过水合破坏脱脂斑滴丸。在体内实验表明,血浆水平时间曲线和峰值浓度下的冠心病和水合脱脂剂的区域高于CPHGs。此外,用CPHGSPD,药代动力学参数与具有水合脱脂剂的药代动力学参数类似。这些结果表明,CPHGSPD提供了改善口头交付的好方法.CPHGS。 (c)2016年Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号